Rockefeller Capital Management
AYTU icon

Rockefeller Capital Management’s AYTU BioPharma AYTU Stock Holding History

Rockefeller Capital Management’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22 Hold
10
– – ﹤0.01% 4710
2026
Q1 		$27 Buy
+10
New +$26 ﹤0.01% 4659

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Rockefeller Capital Management's AYTU Position: Q2 2026 in Review

Rockefeller Capital Management held its AYTU BioPharma (AYTU) position steady in Q2 2026 at 10 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #4710.

Rockefeller Capital Management first reported a position in AYTU in Q1 2026 and has held it in 2 quarters since. The position peaked at $27 in Q1 2026. 38 funds tracked by Wall St. Rank hold AYTU as of Q2 2026.

  • Rockefeller Capital Management held 10 shares of AYTU BioPharma worth $22 as of Q2 2026.
  • Rockefeller Capital Management left its AYTU BioPharma share count unchanged in Q2 2026.
  • AYTU BioPharma made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4710 holding.
  • Rockefeller Capital Management first reported a position in AYTU BioPharma in Q1 2026 and has held it in 2 quarters since.
  • Rockefeller Capital Management's AYTU BioPharma position peaked at $27 in Q1 2026.
  • 38 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.